PROPHYLACTIC AND / OR THERAPEUTIC AGENT FOR HEPATIC DISEASE.

摘要

the present invention addresses the problem of providing a medicinal composition and a drug combination by which non-alcoholic fatty liver disease and non-alcoholic steatohepatitis can be prevented and / or treated. the present invention provides a combination of a peroxisome proliferator receptor activated agonist (ppar) with a sodium and glucose cotransporter 2 inhibitor (sglt2), which should be used to prevent and / or treat non-alcoholic fatty liver disease and steat - non-alcoholic hepatitis.